Bicycle Therapeutics Ltd (BCYC)vsInsmed Inc (INSM)
BCYC
Bicycle Therapeutics Ltd
$4.50
+3.69%
HEALTHCARE · Cap: $301.75M
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 735% more annual revenue ($606.42M vs $72.59M). BCYC leads profitability with a 0.0% profit margin vs -2.1%. BCYC earns a higher WallStSmart Score of 43/100 (D).
BCYC
Hold43
out of 100
Grade: D
INSM
Hold39
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
No standout strengths identified
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -31.2% — below average capital efficiency
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : BCYC
The strongest argument for BCYC centers on Price/Book. Revenue growth of 11.9% demonstrates continued momentum.
Bull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bear Case : BCYC
The primary concerns for BCYC are EPS Growth, Market Cap, Profit Margin.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Key Dynamics to Monitor
BCYC profiles as a value stock while INSM is a turnaround play — different risk/reward profiles.
BCYC carries more volatility with a beta of 1.61 — expect wider price swings.
BCYC is growing revenue faster at 11.9% — sustainability is the question.
BCYC generates stronger free cash flow (-21M), providing more financial flexibility.
Bottom Line
BCYC scores higher overall (43/100 vs 39/100) and 11.9% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Bicycle Therapeutics Ltd
HEALTHCARE · BIOTECHNOLOGY · USA
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, is developing a class of drugs for diseases that are not served by existing treatments. The company is headquartered in Cambridge, the United Kingdom.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?